RT Journal Article
SR Electronic
T1 exRNA Signatures in Extracellular Vesicles and their Tumor-Lineage from Prostate Cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.28.20190009
DO 10.1101/2020.09.28.20190009
A1 Dogra, Navneet
A1 Ahsen, Mehmet E.
A1 Kozlova, Edgar EG
A1 Chen, Tzu-yi
A1 Allette, Kimaada
A1 Olsen, Reena
A1 Han, Dan
A1 Kim, Sung-Cheol
A1 Gifford, Stacey M.
A1 Smith, Joshua T.
A1 Wunsch, Benjamin H.
A1 Weil, Rachel
A1 Bhatt, Kamala
A1 Yadav, Kamlesh K.
A1 Vlachos, Konstantinos
A1 Nair, Sujit
A1 Gordon, Ronald E.
A1 Smith, Melissa
A1 Sebra, Robert P.
A1 Margolin, Adam
A1 Sahoo, Susmita
A1 Tewari, Ashutosh K.
A1 Cordon-Cardo, Carlos
A1 Losic, Bojan
A1 Stolovitzky, Gustavo
YR 2020
UL http://medrxiv.org/content/early/2020/09/30/2020.09.28.20190009.abstract
AB Circulating extracellular vesicles (EVs) present in the bodily fluids of patients with cancer may provide non-invasive access to the tumor tissue. Yet, the transcriptomic lineage of tumor-derived EVs before and after tumor-resection remains poorly understood. Here, we established 60 total small RNA-sequencing profiles from 17 aggressive prostate cancer (PCa) patient’s tumor and adjacent normal tissue, and EVs isolated from urine, serum, and cancer cell culture media. We interrogated the key satellite alteration in tumor-derived EVs and found that resection of tumor prostate tissue leads to differential expression of reactive oxygen species (ROS), P53 pathways, inflammatory/cytokines, oncogenes, and tumor suppressor genes in the EV nanosatellites. Furthermore, we provide a set of novel EV-specific RNA signature, which are present in cancer but are nonexistent in post-resection patients with undetectable cancer. Finally, using a de novo RNAseq assembly followed by characterization of the small RNA landscape, we found novel small RNA clusters (smRCs) in the EVs, which reside in the unannotated regions. Novel smRCs were orthogonally validated for their differential expression in the ‘biomarker discovery’ cohort using RT-qPCR. We demonstrate that circulating tumor EVs provide a glimpse of the tumor tissue biology, resolving a major bottleneck in the current liquid biopsy efforts. Secretory vesicles appear to be playing a key role in non-canonical Wnt signaling and miRNA pathways, similar to the circulating tumor cells (CTCs), hence, we propose that such vesicles be called circulating tumor extracellular vesicles (CTEVs).Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding is provided from IBM and Icahn School of Medicine at Mount Sinai.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Review Board approved protocols (GCO # 06-0996, 14-0318, and surgical consent)at the Department of Urology, Icahn School of Medicine at Mount Sinai, New York, 10029All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe RNAseq data is published on exRNA atlas https://exrna-atlas.org/. The data will also be available on GEO after publication. https://exrna.org/